This inventor holds 2 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignee: Selectimmune Pharma Ab. Active years: 2021-2023.
Company Filing History:
1 out of 1 Years Active: 2021-2023
Title: Biography of Ines Ambite
Introduction: Ines Ambite is an accomplished inventor based in Lund, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents.
Latest Patents: Ines holds two patents, including one for an inhibitor of RNA polymerase II. This inhibitor targets proteins such as cyclin kinase 12 (CDK12) and its recruiting protein PAF1C. The inhibitors she has developed are useful in therapies aimed at suppressing protein expression, making them potential candidates for immunosuppressants, anti-inflammatory, or anti-infection agents. Her other patent involves a method for treating cystitis, specifically acute cystitis, through the administration of effective reagents.
Career Highlights: Ines is currently associated with Selectimmune Pharma AB, where she continues her innovative work in the biotechnology sector. Her research focuses on developing novel therapeutic strategies that address critical health issues.
Collaborations: Throughout her career, Ines has collaborated with notable colleagues, including Catharina Svanborg and Nina Filenko. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion: Ines Ambite is a pioneering inventor whose work in biotechnology has the potential to impact therapeutic practices significantly. Her dedication to innovation and collaboration continues to drive her success in the field.